NGeneBio Co., Ltd. (KOSDAQ:354200)
South Korea
· Delayed Price · Currency is KRW 1,938.00
+95.00 (5.15%)
At close: Aug 8, 2025, 3:30 PM KST
NGeneBio Revenue
NGeneBio had revenue of 2.04B KRW in the quarter ending March 31, 2025, with 133.05% growth. This brings the company's revenue in the last twelve months to 6.85B, up 78.03% year-over-year. In the year 2024, NGeneBio had annual revenue of 5.69B with 30.80% growth.
Revenue (ttm)
6.85B
Revenue Growth
+78.03%
P/S Ratio
7.10
Revenue / Employee
118.16M
Employees
58
Market Cap
48.62B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 5.69B | 1.34B | 30.80% |
| Dec 31, 2023 | 4.35B | -6.67B | -60.51% |
| Dec 31, 2022 | 11.02B | 3.85B | 53.81% |
| Dec 31, 2021 | 7.16B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition